New plasma and gas combo may fight deadly heart surgery infections
NCT ID NCT04617353
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a combined treatment using air-plasma flow and nitric oxide gas to prevent and treat wound infections after heart surgery. It included 80 patients with mediastinitis, a serious chest infection. The goal was to see if this approach could reduce infection, improve wound healing, and lower death rates.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- air-plasma flow and nitric oxide therapy
- What this could lead to
- If successful, this could offer a new way to prevent and treat serious wound infections after heart surgery, potentially reducing complications and deaths.
- What could go wrong
- This is a small, completed study with 80 participants, so results may not apply to all patients. The treatment is a procedure, not a drug, and its effectiveness compared to standard care is uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MEDIASTINITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
TomskNRMC
Tomsk, Tomskay Oblast, 634012, Russia
More trials for these conditions
Other studies related to the condition(s) this trial covers.